A 2022 Novo-funded study that followed clinical trial participants showed that on average, patients regained two-thirds of ...

New research suggests that many people who stop using GLP-1 drugs like Ozempic maintain their weight loss, countering previous studies.

Real-world data suggests weight loss durability post-GLP-1 drug discontinuation Study suggests weight regain may be less common than clinical trial extensions indicate Behavioral changes may aid ...

Many patients using GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, an analysis of ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A combination image shows an injection pen of Zepbound, Eli Lilly's weight loss drug, and boxes of Wegovy, made by ...

Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight quickly when they stop treatment, according to an analysis of real-world data shared with ...

GLP-1 drugs may be able to sustain their weight loss effects even months after discontinuing the popular obesity drugs, ...

Since the beginning of the COVID-19 pandemic, public health experts have worried about people getting infected with the influenza virus and SARS-CoV-2 at the same time, a disease sometimes called ...

A real-world study by nference suggests that patients using GLP-1 drugs for weight loss may not experience rapid weight regain after discontinuation. Though the study contradicts previous clinical ...